Clinical Trials Logo

Clinical Trial Summary

Multiple Sclerosis (MS) is inflammatory, demyelinating and autoimmune disease of the central nervous system. It is usually seen with relapses and genetic and environmental factors play a role in the etiology. Neurological symptoms seen in MS restrict the patient's daily activity and social role participation. Mobility problems and fatigue are the most important reasons of role limitations and decreased quality of life. The importance of exercise training in disease management has been emphasized in recent years. However, few studies have investigated the effects of task-oriented trainings on symptoms of the disease. The aim of this sudy is to investigate the effects of task-oriented training additional to combined exercise training on functional capacity, mobility, balance, fatigue and quality of life in patients with MS.

Clinical Trial Description


Study Design

Related Conditions & MeSH terms

NCT number NCT03497468
Study type Interventional
Source Bezmialem Vakif University
Contact Kamer Unal-Eren, PT, PhD
Phone +902125232288
Status Not yet recruiting
Phase N/A
Start date April 2018
Completion date June 2018

See also
  Status Clinical Trial Phase
Active, not recruiting NCT02861014 - A Study of Ocrelizumab in Participants With Relapsing Remitting Multiple Sclerosis (RRMS) Who Have Had a Suboptimal Response to an Adequate Course of Disease-Modifying Treatment (DMT) Phase 3
Terminated NCT01435993 - Multiple Doses of Anti-NOGO A in Relapsing Forms of Multiple Sclerosis Phase 1
Recruiting NCT03653585 - Cortical Lesions in Patients With Multiple Sclerosis
Completed NCT02410200 - Study of the Effect of BG00012 on MRI Lesions and Pharmacokinetics in Pediatric Subjects With RRMS Phase 2
Completed NCT01116427 - A Cooperative Clinical Study of Abatacept in Multiple Sclerosis Phase 2
Completed NCT01108887 - An Observational Study for the Assessment of Adherence, Effectiveness and Convenience of Rebif® Treatment in Relapsing Multiple Sclerosis Patients Using RebiSmartâ„¢. N/A
Completed NCT01141751 - An Observational Study Comparing Multiple Sclerosis International Quality of Life Questionnaire (MusiQoL) and Multiple Sclerosis Quality of Life-54 Instrument (MSQOL-54) in Relapsing Multiple Sclerosis (RMS) Patients on Long-term Rebif® Therapy N/A
Completed NCT00097331 - Three Months Treatment With SB683699 In Patients With Relapsing Multiple Sclerosis Phase 2
Recruiting NCT01909492 - Relaxin in Multiple Sclerosis (MS)
Completed NCT00071838 - Zenapax (Daclizumab) to Treat Relapsing Remitting Multiple Sclerosis Phase 2
Active, not recruiting NCT02545868 - A Study to Evaluate the Effects of Ocrelizumab on Immune Responses In Participants With Relapsing Forms of Multiple Sclerosis Phase 3
Completed NCT03718026 - The Reliability, Validity, and Responsiveness of the Timed 360° Turn Test in Patients With Multiple Sclerosis
Completed NCT02687919 - Evaluation of a Modified Paleolithic Dietary Intervention in the Treatment of Relapsing-Remitting Multiple Sclerosis N/A
Recruiting NCT01453868 - The Effects of Aerobics Training on Balance in Patients With Multiple Sclerosis Phase 0
Completed NCT01279876 - Melatonin in Relapsing-Remitting Multiple Sclerosis Patients Phase 2
Completed NCT02275741 - Study to Investigate the Immune Response and Safety of Prophylactic Vaccines in Patients Treated for Multiple Sclerosis
Terminated NCT00780455 - Rehabilitation Study in MS Patients Phase 4
Completed NCT00548405 - Comparison of Alemtuzumab and Rebif® Efficacy in Multiple Sclerosis, Study Two Phase 3
Completed NCT00242177 - Pilot Test of ACTOS in Multiple Sclerosis: Safety and Tolerability Phase 1
Recruiting NCT03205280 - Clinical Decision Support System (CADIMS) for MS Diagnostic